ACR Meeting Abstracts
Abstract Number: 57 • ACR/ARP Annual Meeting 2019
Veronica Pulito-Cueto1, Sara Remuzgo-Martínez 1, Fernanda Genre 1, Leticia Lera-Gomez 1, Veronica Mijares 1, Pilar Alonso Lecue 2, Victor Manuel Mora Cuesta 2, David Iturbe 3, Sonia M. Fernández Rozas 2, Ricardo Blanco 4, Alfonso Corrales 1, Jose Manuel Cifrian Martínez 2, Raquel López-Mejías 1 and Miguel A Gonzalez-Gay 4, 1Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, Santander, Spain, 2Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL; and Pneumology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain, Santander, Spain, 3Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain; and Pneumology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain, Santander, Spain, 4Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain
Background/Purpose: Interstitial lung disease (ILD) is one of the most significant comorbidities that contributes to the increased mortality observed in patients with rheumatoid arthritis (RA)…